Developing & licensing the
world’s strongest, most
effective broad-spectrum antibiotics for
infectious skin diseases and wound care.
About Our transdermal technology
Strong Advanced Biological Coverage (ABC) topical antibiotics that are highly concentrated, penetrate faster, and much more effective than conventional antibiotics. Our advanced transdermal delivery system kills all harmful gram-positive & gram-negative bacteria that are available for testing and delivers results within 24 hours, compared to 5-7 days for others.
Our target markets globally
New antibiotic
A New FDA-Registered & Patent Approved Topical Antibiotic
Strongest first aid & antibiotic
One of the world’s strongest topical tirst aid & antibiotics for OTC Use.
Kills all type of bacteria
Vitastem Ultra kills all harmful bacteria that have ever been available for testing (bacteria associated with acne, eczema, psoriasis, diabetic wounds, cuts & scrapes), including staph infection, and MRSA (flesh eating bacteria).
New Antiniotic
A New FDA-Registered & Patent Pending Topical Antibiotic
Strongest First Aid & Antibiotic
One of The World’s Strongest Topical First Aid & Antibiotics for OTC Use.
Kills all type of bacteria
Vitastem Ultra kills all harmful bacteria that have ever been available for testing (bacteria associated with acne, eczema, psoriasis, diabetic wounds, cuts & scrapes), including staph infection, and MRSA (flesh eating bacteria).
ViaDerma has been featured In
Founded in 2014, ViaDerma Inc. (VDRM) is a publicly traded pharmaceutical company committed to bringing new products to market and licensing its innovative technology to current leaders in the pharmaceutical industry in a wide variety of therapeutic areas.
ViaDerma’s lead product Vitastem utilizes an innovative transdermal delivery method to apply any active ingredient to a topical drug.